San Francisco, CA, United States of America

Sukanto Sinha

This inventor holds 38 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Plasma Kallikrein Inhibitors. Top assignees: Elan Pharmaceuticals, Inc., Activesite Pharmaceuticals, Inc., Athena Neurosciences, Inc.. Active years: 1994-2025.

USPTO Granted Patents = 38 (Patent Applications = 2)

% Patents Active = 76.3

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 3.8

ph-index = 12

Forward Citations = 613(Granted Patents)

Company Filing History:

19 out of 202

Elan Pharmaceuticals, Inc.

patents

9 out of 9

Activesite Pharmaceuticals, Inc.

patents

7 out of 35

Athena Neurosciences, Inc.

patents

4. 5 out of 4,507

Eli Lilly and Company

Joslin Diabetes Center, Inc.

patents

7. 3 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2025

Loading Chart...

Areas of Expertise:

Plasma Kallikrein

Beta-Secretase

Prodrugs

Glycosylation Variants

Transgenic Rodents

APP Cleavage

Inhibition Methods

Amyloidin Protease

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12240818 - Crystalline forms of plasma kallikrein inhibitors (2025-03-04),

2. 11306061 - Crystalline forms of plasma kallikrein inhibitors (2022-04-19),

3. 11267790 - Processes for preparing plasma kallikrein inhibitors (2022-03-08),

4. 9206123 - Prodrugs of inhibitors of plasma kallikrein (2015-12-08),

5. 8691861 - Prodrugs of inhibitors of plasma kallikrein (2014-04-08),

6. 8658685 - Methods for treatment of kallikrein-related disorders (2014-02-25),

7. 8609866 - Prodrugs of inhibitors of plasma kallikrein (2013-12-17),

8. 8258170 - Inhibitors of plasma kallikrein (2012-09-04),

9. 7977380 - Inhibitors of plasma kallikrein (2011-07-12),

10. 7718413 - Glycosylation variants of BACE (2010-05-18),

11. 7625944 - Inhibitors of plasma kallikrein (2009-12-01),

12. 7608749 - Monitoring APP cleavage in transgenic rodents comprising an APP Swedish mutation (2009-10-27),

13. 7514408 - β-secretase enzyme compositions and methods (2009-04-07),

14. 7482136 - Glycosylation variants of BACE (2009-01-27),

15. 7456007 - β-secretase enzyme compositions and methods (2008-11-25),

Title: The Innovative Journey of Sukanto Sinha

Introduction: Sukanto Sinha, a visionary inventor based in San Francisco, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Sinha's latest patents include a cutting-edge artificial intelligence algorithm for predictive analytics in healthcare, a revolutionary renewable energy storage system, and a novel cybersecurity solution for IoT devices.

Career Highlights: With a background in computer science and engineering, Sukanto Sinha has a successful track record of developing innovative solutions. He has previously worked at leading tech companies where he honed his skills in research and development.

Collaborations: Sinha has collaborated with top research institutions and universities to further advance his inventions. His partnerships with industry experts have led to the successful implementation of his patented technologies in real-world applications.

Conclusion: Sukanto Sinha's relentless pursuit of innovation and his passion for creating technology that makes a positive impact on society have solidified his reputation as a pioneering inventor in the tech industry.